CorMedix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	178.09	144.84	40.65	43.64	43.15	53.32
Short-Term Investments	-	3.69	11.04	32.39	15.64	12.15
Cash & Short-Term Investments	178.09	148.53	51.69	76.03	58.79	65.47
Cash Growth	129.78%	187.36%	-32.02%	29.32%	-10.20%	41.24%
Accounts Receivable	154.81	171.23	51.65	-	-	0.05
Inventory	30.73	29.72	7.6	2.11	-	0
Other Current Assets	19.49	17.57	3.63	1.31	0.76	0.95
Total Current Assets	383.11	367.05	114.58	79.45	59.55	66.47
Net Property, Plant & Equipment	6.17	9.93	2.32	2.51	2.38	2.37
Other Intangible Assets	368.77	379.07	1.84	-	-	-
Goodwill	30	30	-	-	-	-
Other Long-Term Assets	27.58	40.09	0.11	0.1	0.1	0.1
Total Assets	815.64	826.14	118.85	82.06	62.04	68.95
Accounts Payable	12.83	7.88	1.72	4.28	2.2	2.21
Accrued Expenses	112.77	161.92	31.95	6.97	3.97	3.01
Current Portion of Leases	-	1.45	0.17	0.15	0.13	0.12
Other Current Liabilities	3.18	3.02	-	-	-	-
Total Current Liabilities	128.78	174.27	33.84	11.4	6.31	5.35
Long-Term Debt	144.89	144.63	-	-	-	-
Long-Term Leases	-	2.84	0.35	0.52	0.67	0.8
Other Long-Term Liabilities	104.93	99.1	-	-	-	-
Total Long-Term Liabilities	249.81	246.57	0.35	0.52	0.67	0.8
Total Liabilities	378.59	420.84	34.19	11.92	6.98	6.15
Preferred Stock	-	-	-	0	0	0
Common Stock	0.08	0.08	0.06	0.05	0.04	0.04
Additional Paid-in Capital	574.94	581.8	424.13	391.69	330.3	308.33
Accumulated Other Comprehensive Income	0	0	0.09	0.09	0.08	0.09
Retained Earnings	-137.97	-176.58	-339.63	-321.7	-275.36	-245.66
Shareholders' Equity	437.05	405.31	84.66	70.14	55.06	62.8
Total Liabilities & Equity	815.64	826.14	118.85	82.06	62.04	68.95
Total Debt	144.89	148.91	0.52	0.67	0.8	0.92
Net Cash (Debt)	33.2	-0.38	51.17	75.36	57.99	64.54
Net Cash Growth	-	-	-32.10%	29.96%	-10.15%	42.43%
Net Cash Per Share	0.39	-0.01	0.87	1.48	1.44	1.71
Book Value	437.05	405.31	84.66	70.14	55.06	62.8
Book Value Per Share	5.07	5.05	1.44	1.38	1.37	1.67
Tangible Book Value	38.28	-3.77	82.81	70.14	55.06	62.8
Tangible Book Value Per Share	0.44	-0.05	1.41	1.38	1.37	1.67

SEC Filings: 10-K · 10-Q